Yoshiyasu Maehata
Papers
1
Total Citations
2
H-Index
1
About
Yoshiyasu Maehata is a radiation oncologist whose work centers on the precision treatment of oligometastatic disease, particularly through stereotactic body radiotherapy (SBRT). His most-cited paper, "Stereotactic Body Radiotherapy for Lymph Node Oligometastases" (2019), provides critical insights into the safety and efficacy of delivering high-dose, ablative radiation to isolated lymph node metastases. This contribution is pivotal in the evolving paradigm of metastasis-directed therapy, offering a non-invasive alternative that can delay systemic treatment escalation and improve patient quality of life. While his citation count is modest, Maehata’s research addresses a clinically significant niche—optimizing SBRT for challenging anatomical sites—and has informed institutional protocols for managing oligometastatic cancer. His work underscores the importance of balancing tumor control with normal tissue sparing, a core challenge in modern radiation oncology. For students and researchers, Maehata’s focus on lymph node oligometastases exemplifies how targeted, evidence-based radiotherapy can transform the management of advanced cancer, bridging the gap between palliative and curative intent.
Research Focus
Key Achievements
Top Papers
- 1Stereotactic Body Radiotherapy for Lymph Node Oligometastases.2 citations · 2019